Able Biolabs’ capabilities encompass the full range of preclinical research needs. We have non-GLP in-house facilities and work with trusted partners to support GLP activities. Whether you’re developing a new drug or a consumer product, we generate the necessary scientific validation to support your needs.
Our team of PhD-level scientists can perform previously validated protocols or work with you to develop and refine models based on both parties’ shared expertise. Our process is transparent and collaborative in order to best facilitate the progress of your research program.
We leverage traditional cell-based models as well as ex vivo approaches such as air-liquid interface and organoids to support your initial proof of concept work